Inga Ellzey Billing Companies Advises Dermatology Practices to Conduct Mid-Year Revenue Cycle Reviews
Inga Ellzey Billing Companies is urging dermatology practices to perform mid-year revenue cycle assessments in order to identify and address potential financial issues before year-end. The company highlights that overall collection totals may not reflect a practice's true financial health, emphasizing the importance of reviewing key performance indicators such as net collection ratio, denial trends, accounts receivable aging, and first-pass claim acceptance. According to Inga Ellzey, Owner of the billing firm, recurring denials or uncollected revenue can quietly impact profitability. Identifying patterns in payer behavior, coding errors, authorization issues, or workflow inefficiencies early allows practices time to correct them before year-end reporting. Even small improvements in these areas could enhance cash flow and support staffing, technology upgrades, or practice expansion. Inga Ellzey Billing Companies has over 40 years of experience in dermatology billing and currently serves more than 120 practices nationwide.
Topics: denial management dermatology practices healthcare billing revenue cycle check